Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/143305
Title: ON THE USE OF OVERT ANTI-COUNTERFEITING TECHNOLOGIES
Authors: GAO YUETAO
Keywords: anti-counterfeiting, overt technologies, entry, pricing, pharmaceutical industry
Issue Date: 11-Jan-2016
Citation: GAO YUETAO (2016-01-11). ON THE USE OF OVERT ANTI-COUNTERFEITING TECHNOLOGIES. ScholarBank@NUS Repository.
Abstract: MANY PHARMACEUTICAL COMPANIES USE OVERT ANTI-COUNTERFEITING TECHNOLOGIES (OACTS) TO FIGHT COUNTERFEITERS. I SHOW THAT THERE MAY BE AN INVERTED U-SHAPED RELATIONSHIP BETWEEN THE COMPLEXITY OF THE OACT AND THE MAGNITUDE OF COUNTERFEIT MEDICINE PURCHASES. ON THE ONE HAND, ADOPTING AN OACT IMPOSES A SIGNIFICANT ENTRY COST ON COUNTERFEITERS, CAUSING FEWER COUNTERFEITERS TO ENTER THE DUBIOUS SOURCE (A COUNTERFEITERS? ENTRY-DAMPENING EFFECT). ON THE OTHER HAND, MORE PATIENTS HEAD TO THIS DUBIOUS SOURCE RATHER THAN THE RELIABLE SOURCE OWING TO THE INCREASED CHANCE OF OBTAINING A GENUINE DRUG (A PATIENTS? DEMAND-ENHANCING EFFECT). WHEN THE SELECTED OACT IS SUFFICIENTLY COMPLEX TO REPLICATE, THE FORMER EFFECT OVERRIDES THE LATTER AND THUS THE PROBLEM OF COUNTERFEIT PURCHASING IS RELIEVED. HOWEVER, WHEN THE OACT IS NOT ADEQUATELY SOPHISTICATED, THE LATTER EFFECT MORE THAN OFFSETS THE FORMER. THIS LEADS TO AN ANTI-COUNTERFEITING TRAP: THE USE OF A RUDIMENTARY OACT MAY BEGET MORE COUNTERFEIT PURCHA
URI: http://scholarbank.nus.edu.sg/handle/10635/143305
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Thesis.pdf628.4 kBAdobe PDF

OPEN

NoneView/Download

Page view(s)

17
checked on Aug 9, 2018

Download(s)

10
checked on Aug 9, 2018

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.